Accès gratuit
Numéro
Med Sci (Paris)
Volume 27, Numéro 3, Mars 2011
Page(s) 261 - 267
Section M/S revues
DOI https://doi.org/10.1051/medsci/2011273261
Publié en ligne 30 mars 2011
  1. FriedensteinAJ, ChailakhjanRK, LalykinaKS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970 ; 3 : 393-403. [PubMed]
  2. PittengerMF, MackayAM, BeckSC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999 ; 284 : 143-147. [CrossRef] [PubMed]
  3. DelormeB, RingeJ, GallayN, et al. Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells. Blood 2008 ; 111 : 2631-2635. [CrossRef] [PubMed]
  4. CharbordP, LivneE, GrossG, et al. Human bone marrow mesenchymal stem cells: a systematic reappraisal via the genostem experience. Stem Cell Rev 2010 ; (online).
  5. BiancoP, RobeyPG, SimmonsPJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008 ; 2 : 313-319. [CrossRef] [PubMed]
  6. UccelliA, MorettaL, PistoiaV. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008 ; 8 : 726-736. [CrossRef] [PubMed]
  7. Le BlancK, RingdenO. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol 2006 ; 18 : 586-591. [CrossRef] [PubMed]
  8. SacchettiB, FunariA, MichienziS, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007 ; 131 : 324-336. [CrossRef] [PubMed]
  9. SensebeL, BourinP. Mesenchymal stem cells for therapeutic purposes. Transplantation 2009 ; 87 : S49-S53. [CrossRef] [PubMed]
  10. GimbleJM, KatzAJ, BunnellBA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007 ; 100 : 1249-1260. [CrossRef] [PubMed]
  11. NoelD, CatonD, RocheS, et al. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008 ; 314 : 1575-1584. [CrossRef] [PubMed]
  12. JansenBJ, GilissenC, RoelofsH, et al. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev 2010 ; 19 : 481-490. [CrossRef] [PubMed]
  13. LoefflerM, PottenC. Stem cells and cellular pedigrees- a conceptual introduction. In : PottenC, ed.Stem cells. San Diego : Academic Press, 1997 : 1-28. [CrossRef]
  14. LoefflerM, RoederI. Tissue stem cells: definition, plasticity, heterogeneity, self-organization and models–a conceptual approach. Cells Tissues Organs 2002 ; 171 : 8-26. [CrossRef] [PubMed]
  15. LoefflerM, RoederI. Conceptual models to understand tissue stem cell organization. Curr Opin Hematol 2004 ; 11 : 81-87. [CrossRef] [PubMed]
  16. HuangS. Reprogramming cell fates: reconciling rarity with robustness. Bioessays 2009 ; 31 : 546-560. [CrossRef] [PubMed]
  17. KaernM, ElstonTC, BlakeWJ, CollinsJJ. Stochasticity in gene expression: from theories to phenotypes. Nat Rev Genet 2005 ; 6 : 451-464. [CrossRef] [PubMed]
  18. KrinnerA, HoffmannM, LoefflerM, et al. Individual fates of mesenchymal stem cells in vitro. BMC Syst Biol 2010 ; 4 : 73. [CrossRef] [PubMed]
  19. CharbordP. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther 2010 ; 21 : 1045-1056. [CrossRef] [PubMed]
  20. HorwitzEM, GordonPL, KooWK, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002 ; 99 : 8932-8937. [CrossRef]
  21. AuP, TamJ, FukumuraD, JainRK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008 ; 111 : 4551-4558. [CrossRef] [PubMed]
  22. Alvarez-DoladoM, PardalR, Garcia-VerdugoJM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003 ; 425 : 968-973. [CrossRef] [PubMed]
  23. BarzilayR, MelamedE, OffenD. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible. Stem Cells 2009 ; 27 : 2509-2515. [CrossRef] [PubMed]
  24. TakashimaY, EraT, NakaoK, et al. Neuroepithelial cells supply an initial transient wave of MSC differentiation. Cell 2007 ; 129 : 1377-1388. [CrossRef] [PubMed]
  25. KurodaY, KitadaM, WakaoS, et al. Unique multipotent cells in adult human mesenchymal cell populations. Proc Natl Acad Sci USA 2010 ; 107 : 8639-8643. [CrossRef]
  26. JiangY, JahagirdarBN, ReinhardtRL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002 ; 418 : 41-49. [CrossRef] [PubMed]
  27. SongL, TuanRS. Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. Faseb J 2004 ; 18 : 980-982. [PubMed]
  28. DelormeB, RingeJ, PontikoglouC, et al. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells 2009 ; 27 : 1142-1151. [CrossRef] [PubMed]
  29. SongL, WebbNE, SongY, TuanRS. Identification and functional analysis of candidate genes regulating mesenchymal stem cell self-renewal and multipotency. Stem Cells 2006 ; 24 : 1707-1718. [CrossRef] [PubMed]
  30. ZukPA, ZhuM, AshjianP, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002 ; 13 : 4279-4295. [CrossRef] [PubMed]
  31. RodriguezAM, PisaniD, DechesneCA, et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. Exp Med 2005 ; 201 : 1397-1405. [CrossRef]
  32. HorwitzEM, DominiciM. How do mesenchymal stromal cells exert their therapeutic benefit?. Cytotherapy 2008 ; 10 : 771-774. [CrossRef] [PubMed]
  33. KimY, KimH, ChoH, et al. Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007 ; 20 : 867-876. [CrossRef] [PubMed]
  34. HorwitzEM, ProckopDJ, FitzpatrickLA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999 ; 5 : 309-313. [CrossRef] [PubMed]
  35. YoonCH, KoyanagiM, IekushiK, et al. Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment. Circulation 2010 ; 121 : 2001-2011. [CrossRef] [PubMed]
  36. MagginiJ, MirkinG, BognanniI, et al. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 2010 ; 5 : e9252. [CrossRef] [PubMed]
  37. CorreJ, MahtoukK, AttalM, et al. Bone marrow mesenchymal stem cells are abnormal in multiple myeloma. Leukemia 2007 ; 21 : 1079-1088. [PubMed]
  38. MénardC, TarteK. Immunosuppression et cellules souches mésenchymateuses : mieux comprendre une propriété thérapeutique majeure. Med Sci (Paris) 2011 ; 27 : 269-274. [CrossRef] [EDP Sciences] [PubMed]
  39. ZiporiD. À la recherche d’une définition moléculaire plus que descriptive pour les cellules souches. Med Sci (Paris) 2011 ; 27 : 303-307. [CrossRef] [EDP Sciences] [PubMed]
  40. JorgensenC, DeschaseauxF, Planat-BenardV, GabisonE. Les cellules souches mésenchymateuses : actualités thérapeutiques. Med Sci (Paris) 2011 ; 27 : 275-284. [CrossRef] [EDP Sciences] [PubMed]
  41. VinatierC, BordenaveL, GuicheuxJ, AmédéeJ. Les cellules souches en ingénierie des tissus ostéoarticulaires et vasculaires. Med Sci (Paris) 2011 ; 27 : 289-296. [CrossRef] [EDP Sciences] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.